Home LiteratureArticle Details
PMID: 11344574 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.

The Journal of clinical investigation ·Vol. 53 ·No. 2 ·1974-02-00 ·Pages 591-9

Goetzl EJ, Austen KF

Abstract

The interaction of human neutrophils adherent to plastic petri dishes with the purified chemotactic factors C5a and kallikrein increased their rate of aerobic glycolysis 25-120% and the activity of their hexose monophosphate shunt (HMPS) 100-600%, reaching a plateau after 2 hr at 37 degrees C. The stimulation of either pathway required a chemotactically active stimulus since neither C5 nor prekallikrein or inactivated kallikrein could enhance metabolic activity. Marked suppression of the neutrophil chemotactic response by preincubation with a chemotactic factor to achieve deactivation, 5 x 10(-7) M diisopropyl fluorophosphate, or the neutrophil immobilizing factor (NIF) did not prevent the stimulation of HMPS activity or glycolysis by chemotactic factors. The metabolic inhibitors iodoacetate and 6-aminonicotinamide at concentrations which blocked enhancement of glycolysis or HMPS activity, respectively, partially suppressed the chemotactic response of neutrophils to the chemotactic factors. The capacity of a chemotactic factor to stimulate glucose metabolism of human neutrophils is associated with a maximal chemotactic response, but this stimulation is not alone sufficient for chemotaxis.

MeSH Terms
Aerobiosis Cells, Cultured Chemotactic Factors/metabolism,pharmacology Complement C5a/metabolism,pharmacology Fluorides/metabolism,pharmacology Glucose/metabolism Glycolysis Humans Kallikreins/metabolism,pharmacology Neutrophils/drug effects,metabolism Pentose Phosphate Pathway Phosphates/metabolism,pharmacology
Chemicals
Chemotactic Factors Phosphates fluorophosphate Complement C5a Kallikreins Glucose Fluorides
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Goetzl E J
Department of Medicine, Harvard Medical School and Robert B. Brigham Hospital, Boston, Massachusetts 02120, USA.
Austen K F
References (25)
25 references, click to expand
  1. Suppression of metabolic accompaniments of phagocytosis by colchicine.
    Arthritis Rheum. 1965 Dec;8(6):1112-22 PMID: 5884820
  2. Leukocyte motility. I. Method of study, normal variation, effect of physical alterations in environment, and effect of iodoacetate.
    Can J Physiol Pharmacol. 1966 May;44(3):475-85 PMID: 5914367
  3. The chemosuppression of chemotaxis.
    J Exp Med. 1966 Aug 1;124(2):209-26 PMID: 5950689
  4. Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant.
    Clin Chem. 1967 Apr;13(4):314-25 PMID: 6036716
  5. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.
    J Exp Med. 1968 Apr 1;127(4):693-709 PMID: 5642465
  6. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.
    Scand J Clin Lab Invest Suppl. 1968;97:31-50 PMID: 4179066
  7. A neutrophil chemotactic factor from human C'5.
    J Immunol. 1969 Jan;102(1):93-9 PMID: 5765461
  8. Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies.
    J Clin Invest. 1970 Apr;49(4):692-700 PMID: 4392648
  9. A pre-albumin activator of prekallikrein.
    J Immunol. 1970 Oct;105(4):802-11 PMID: 5470521
  10. Alterations of macrophage functions by mediators from lymphocytes.
    J Exp Med. 1971 Jun 1;133(6):1356-76 PMID: 5576335
  11. The interaction in vitro between polymorphonuclear leukocytes and mycoplasma.
    J Exp Med. 1971 Dec 1;134(6):1417-30 PMID: 4942406
  12. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
    J Exp Med. 1972 Jan;135(1):81-97 PMID: 5009705
  13. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    J Exp Med. 1972 Feb 1;135(2):376-87 PMID: 4551218
  14. Quantitative studies of phagocytosis by polymorphonuclear leukocytes: use of emulsions to measure the initial rate of phagocytosis.
    J Clin Invest. 1972 Mar;51(3):615-24 PMID: 4334720
  15. Effect of 6-aminonicotinamide on insulin release and C-14 glucose oxidation by isolated pancreatic rat islets: difference between glucose, tolbutamide and aminophylline.
    Endocrinology. 1972 Jul;91(1):33-8 PMID: 4260250
  16. Cytochalasin B. IV. Inhibition and stimulation of chemotaxis of rabbit and human polymorphonuclear leukocytes.
    J Immunol. 1972 Feb;108(2):396-402 PMID: 4558864
  17. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.
    J Exp Med. 1972 Dec 1;136(6):1564-80 PMID: 4641855
  18. Enhancement of immunologically induced granule exocytosis from neutrophils by cytochalasin B.
    J Immunol. 1973 Jan;110(1):290-3 PMID: 4685405
  19. A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility.
    J Immunol. 1973 Sep;111(3):938-45 PMID: 4741302
  20. A method for assessing the in vitro chemotactic response of neutrophils utilizing 51cr-labeled human leukocytes.
    Immunol Commun. 1972;1(5):421-30 PMID: 4217768
  21. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.
    J Biol Chem. 1959 Jun;234(6):1355-62 PMID: 13654378
  22. The inhibition of erythrophagocytosis in vitro by corticosteroids.
    Trans Assoc Am Physicians. 1960;73:93-102 PMID: 13731952
  23. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.
    J Exp Med. 1962 Mar 1;115:453-66 PMID: 13872176
  24. Metabolic basis of phagocytic activity.
    Physiol Rev. 1962 Jan;42:143-68 PMID: 14454025
  25. ESTIMATION OF PATHWAYS OF CARBOHYDRATE METABOLISM.
    Biochem Z. 1963;338:809-47 PMID: 14087346
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1974-02-00
Pages
591-9
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC301503
Subset
IM
Grants
NIAID NIH HHS · AI-07722 · United States
NIAID NIH HHS · AI-10356 · United States
NCRR NIH HHS · RR-05669 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]